LSP 7 Reports 11.8% Stake in Oculis Holding

Oculis Holding AG reports that LSP 7 and related parties beneficially own 6,950,294 Ordinary Shares as of March 31, 2026.

Rhea-AI Filing Summary

Oculis Holding AG reports that LSP 7 and related parties beneficially own 6,950,294 Ordinary Shares as of March 31, 2026. That stake represents 11.8% of the company based on 59,034,438 Ordinary Shares outstanding. The filing states 1,050,000 shares were purchased by LSP 7 on March 11, 2026, and LSP 7 Management B.V. is the sole director of LSP 7.

Insights

Institutional Ownership Analyst

LSP 7 holds an 11.8% stake in Oculis (6,950,294 shares) as of March 31, 2026.

LSP 7 is the record holder of 6,950,294 Ordinary Shares, representing 11.8% of 59,034,438 shares outstanding. The filing attributes shared voting and dispositive power to the reporting entities and notes a March 11, 2026 purchase of 1,050,000 shares.

Ownership is reported via LSP 7 and its manager, LSP 7 Management B.V.; related individuals are identified but disclaim beneficial ownership. Subsequent filings would be required to track changes.

Corporate Governance Specialist

Filing clarifies voting/dispositive structure and identifies managing directors.

The statement lists shared voting power and shared dispositive power of 6,950,294 shares and names the managing directors of LSP 7 Management B.V.: Martijn Kleijwegt, Rene Kuijten, and Joachim Rothe. Each of these individuals disclaims beneficial ownership in the filing.

Where control resides for governance purposes is presented as shared through the reporting entities; any governance impact depends on future actions or additional filings showing changes.

Key Figures

Shares beneficially owned: 6,950,294 shares Percent of class: 11.8% Shares outstanding: 59,034,438 shares +1 more

4 metrics

Shares beneficially owned 6,950,294 shares Beneficial ownership reported as of <date>March 31, 2026</date>

Percent of class 11.8% Based on 59,034,438 Ordinary Shares outstanding as of <date>March 31, 2026</date>

Shares outstanding 59,034,438 shares Outstanding used to calculate ownership as of <date>March 31, 2026</date>

Recent purchase 1,050,000 shares Purchased by LSP 7 on <date>March 11, 2026</date>

Key Terms

beneficially owned, shared dispositive power, Schedule 13G/A

3 terms

beneficially owned regulatory

"The ownership information presented herein represents beneficial ownership of Ordinary Shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power regulatory

"Shared power to dispose or to direct the disposition of: 6,950,294"

Schedule 13G/A regulatory

"(Amendment No. 2 ) Oculis Holding AG Ordinary Shares"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does LSP 7 report in Oculis (OCS)?

LSP 7 reports beneficial ownership of 6,950,294 shares, equal to 11.8% of the class. This figure is based on 59,034,438 Ordinary Shares outstanding as of March 31, 2026.

When were the shares that underpin this Schedule 13G/A acquired?

The filing notes a purchase of 1,050,000 Ordinary Shares by LSP 7 on March 11, 2026. The ownership percentages are reported as of March 31, 2026.

Who is listed as having voting or dispositive power over these shares?

The filing shows shared voting power and shared dispositive power of 6,950,294 shares, with no sole voting or sole dispositive power reported by the reporting persons.

Which entities and individuals are named in the filing?

The statement is filed on behalf of LSP 7 Cooperatieve U.A. and LSP 7 Management B.V. Managing directors named are Martijn Kleijwegt, Rene Kuijten, and Joachim Rothe, who disclaim beneficial ownership.

What outstanding share count is used to calculate the 11.8% figure?

The percent is calculated using 59,034,438 Ordinary Shares outstanding as of March 31, 2026, which reflects 57,984,438 outstanding at December 31, 2025 plus 1,050,000 purchased by LSP 7.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 04:30 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Oculis Holding AG

(Name of Issuer)

Ordinary Shares, par value CHF 0.01 per share

(Title of Class of Securities)

H5870P102

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): H5870P102

1

Names of Reporting Persons

LSP 7 Cooperatieve U.A.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,950,294.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,950,294.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,950,294.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.8 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): H5870P102

1

Names of Reporting Persons

LSP 7 Management B.V.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,950,294.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 6,950,294.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,950,294.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.8 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Oculis Holding AG
(b)	Address of issuer's principal executive offices: Bahnhofstrasse 20, CH-6300, Zug, Switzerland
Item 2.
(a)	Name of person filing: Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of: LSP 7 Cooperatieve U.A. ("LSP 7"); and LSP 7 Management B.V.
(b)	Address or principal business office or, if none, residence: The principal business address of each of the Reporting Persons is c/o EQT Life Sciences, Johannes Vermeerplein 9, 1071 DV Amsterdam, the Netherlands.
(c)	Citizenship: Each of the Reporting Persons is organized under the laws of the Netherlands.
(d)	Title of class of securities: Ordinary Shares, par value CHF 0.01 per share
(e)	CUSIP No.: H5870P102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The ownership information presented herein represents beneficial ownership of Ordinary Shares of the Issuer as of March 31, 2026, based on 59,034,438 Ordinary Shares outstanding, which consists of (i) 57,984,438 Ordinary Shares outstanding as of December 31, 2025, as disclosed in the Issuer's annual report on Form 20-F filed on March 4, 2026, and (ii) 1,050,000 Ordinary Shares purchased by LSP 7 on March 11, 2026. LSP 7 is the record holder of 6,950,294 Ordinary Shares. LSP 7 Management B.V. is the sole director of LSP 7. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe. As such, LSP 7 Management B.V., Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may be deemed to beneficially own the Ordinary Shares held of record by LSP 7. Each of Mr. Kleijwegt, Mr. Kuijten and Mr. Rothe disclaims beneficial ownership of such shares.
(b)	Percent of class: 11.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 6,950,294
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 6,950,294
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

LSP 7 Cooperatieve U.A.

Signature:	By: LSP 7 Management B.V., its managing director, /s/ Martijn Kleijwegt
Name/Title:	Martijn Kleijwegt, Managing Director
Date:	04/29/2026

Signature:	By: LSP 7 Management B.V., its managing director, /s/ Rene Kuijten
Name/Title:	Rene Kuijten, Managing Director
Date:	04/29/2026

LSP 7 Management B.V.

Signature:	/s/ Martijn Kleijwegt
Name/Title:	Martijn Kleijwegt, Managing Director
Date:	04/29/2026

Signature:	/s/ Rene Kuijten
Name/Title:	Rene Kuijten, Managing Director
Date:	04/29/2026

Exhibit Information

Joint Filing Agreement (previously filed).